Principles of treatment of malignant gliomas in adults: An overview

Reference

• Alderson L. M., Castleberg R. L., Harsh GR I. V., et al. Human gliomas with wild-type p53 expresses bcl-2. Cancer Research 1995; 55: 999–1001
   Google Scholar
• Ameri A., Poisson M., Chauveinc L., et al. Treatment of recurrent malignant supra tentorial gliomas with the association of carboplatin and etoposide: a phase II study. J of Neuro-Oncology 1997; 32: 155–160
   Google Scholar
• Anderson C., Tytell M., Brunso-Bechothold J. Transplantation of cultured type-1 Astrocyte cell suspensions into young, adult and aged rat cortex: cell migration and survival. Int J Dev Neuroscience 1993; 11: 555–568
   Google Scholar
• Andreansky S. S., He B., Gillespie G. Y., Soroceanu L., Markert J., Chou J., Roizman B., Whitley R. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proc Natl Acad Sci USA 1996; 93: 11313–11318
   PubMed Web of Science ®Google Scholar
• Arap W., Knudsen E. S., Wang J. Y., et al. Point mutations can inactivate in vitro and in vivo activities of p16 (INK4A)/CDKN2A in human glioma. Oncogene 1997; 14: 603–609
   Google Scholar
• Asai A., Miyagi Y., Sugiyama A., et al. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J of Neuro-Oncology 1994; 19: 259–268
   PubMedGoogle Scholar
• Azizi SA. Adenovirus mediated gene transfer to astrocytes from adult rats: vehicles for ex vivo gene therapy. J Neurovirology 1997; 3((suppl 1))S 73
   Google Scholar
• Azizi S. A., Stokes D., Augelli B. J., Digirolamo C., Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats. Similarities to astrocyte grafts. Proc Natl Acad Sci (USA) 1998, (in press)
   Google Scholar
• Bailar J. C., Gornik HL. Cancer undefeated. N England J Medicine 1997; 336: 1569–1574
   PubMed Web of Science ®Google Scholar
• Balmaceda C., Fetell M. R., Hesdorffer C. Thiotepa and etoposide treatment of recurrent malignant gliomas: a phase I study. Cancer Chemotherapy & Pharmacology 1997; 40((1))72–74
   Google Scholar
• Barth R. F., Soloway AH. Boron neutron capture therapy of brain tumors - current status and future prospects. J Neuro-Oncology 1997; 33: 3–7
   Google Scholar
• Barth R. F., Yang W., Rotaru J. H., Moeschberger M. L., Joel D. D., Nawwrocky M. M., Goodman J. H., Soloway AH. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophe-nylalanine with or without blood-brain barrier disruption. Cancer Research 1997; 57: 1129–1136
   PubMed Web of Science ®Google Scholar
• Bartus R. T., Elliott P. J., Dean R. L., et al. Experimental Neurology 1996; 142: 14–28
   PubMed Web of Science ®Google Scholar
• Beck-Bomholdt H. P., Dubben H. H., Liertz-Peterson C., Willers H. Hyperfractionation: Where do we stand?. Radiotherapy and Oncology 1997; 43: 1–21
   Google Scholar
• Beutler A. S., Banck M. S., Aguzzi A., Wedekind D., Hedrich HJ. Curing rat glioblastoma: Immune therapy or graft rejection?. Science 1997; 276: 20–21
   Google Scholar
• Black PM. Management of malignant Glioma: Role of surgery in relation to Multi modality Therapy. J Neurovirology 1997, (current issue)
   Google Scholar
• Blomgren H. Brain Tumors. Acta Oncologica 1996; 35((suppl 7))16–21
   Google Scholar
• Bodmer S., Strommer K., Fei K., Siepl C., De Tribolet N., Heid I., Fontana A. Immunosuppression and transforming growth factor beta in glioblastoma: preferential production of transforming growth factor beta-2. J Immunol 1989; 143: 3222–3229
   PubMed Web of Science ®Google Scholar
• Bogler O., Huang H. J., Kleihues P., Cavenee WK. The p53 gene and its role in human brain tumors. GLIA 1995; 15((3))308–327
   Google Scholar
• Boiardi A., Silvana A., Pozzi A., et al. Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy. J of Neuro-Oncology 1997; 34: 179–185
   Google Scholar
• Boring C. C., Squires T. S., Tong T., Montgomery S. Cancer statistics. Ca: a Cancer J for Clinicians 1994; 44: 7–26
   PubMed Web of Science ®Google Scholar
• Boviatsis E. J., Scharf J. M., Chase M., Harrington K., Kowar N. W., Breakfefield X. O., Chiocca EA. Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase. Gene Therapy 1994; 1: 323–331
   PubMed Web of Science ®Google Scholar
• Brady L., Woo D., Markoe A., Dadvarpar S., Karsson U., Rackover M., Peyster R., Embrich J., Miyamoto C., Steplewski Z., Koprowski H. Radioimmuno-therapy with 125I-EGF-425 in patients with brain tumors: Preliminary results of a phase II clinical trial. Antibody Immunoconjugat Radiopharm 1990; 3: 169–179
   Google Scholar
• Brandes A. A., Rigon A., Zampieri P., et al. Early chemotherapy and concurrent radio-chemotherapy in high grade glioma. J of Neuro-Oncology 1996; 30: 247–255
   PubMed Web of Science ®Google Scholar
• Breder J., Ruller S., Ruller E., et al. Induction of cell death by cytokines in cell populations restricted to Gl and G2. Experimental Cell Research 1996; 223: 259–267
   Google Scholar
• Chemausek SD. Insulin-like growth factor I (IGF-1) production by astroglial cells: regulation and importance for epidermal growth factor-induced cell replication. J of Neuroscience Research 1993; 34: 189–197
   Google Scholar
• Culver K. W., et al. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550–1552
   PubMed Web of Science ®Google Scholar
• Czubayko F., Liaudet-Coopman E. D., Aigner A., et al. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nature Medicine 1997; 3: 1137–1140
   PubMed Web of Science ®Google Scholar
• Del Bigio M. R., Colin C., Jacque CM. Fine structure of astroglial integration into host brain following xenografting. J Neuropath & Exp Neurol 1995; 54: 385–394
   Google Scholar
• Dilber M. S., Abedi M. R., Christenson B., et al. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase. in vivo. Cancer Research 1997; 57: 1523–1528
   PubMed Web of Science ®Google Scholar
• Dynlacht B. D., Moberg K., Lees J. A., et al. Specific regulation of E2F family members by cyclin-depen-dent kinases. Molecular & Cellular Biology 1997; 17: 3867–3875
   Google Scholar
• Elliott T. E., Dinapoli R. P., O'Fallon J. R., et al. Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma. J of Neuro-Oncology 1996a; 33: 239–250
   Google Scholar
• Elliott P. J., Hayward N. J., Dean R. L., et al. Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors. Cancer Research 1996b; 56: 3998–4005
   PubMed Web of Science ®Google Scholar
• Emmett C. J., Lawrence J. M., Seeley PJ. Visualization of migration of transplanted astrocytes using polystyrene microspheres. Brain Res 1988; 447: 223–233
   Google Scholar
• Emrich J. G., Bender H., Class R., Eshleman J., Miyamoto C., Brady LW. In vitro evaluation of iodine-125-labeled monoclonal antibody (Mab 425) in human high-grade glioma cells. American J of Clinical Oncology 1996; 19: 601–608
   Google Scholar
• Ezzeddine C. D., et al. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of herpes simplex virus thymidine kinase gene. New Biologist 1991; 3: 608–614
   PubMedGoogle Scholar
• Faillot T., Magdelenat H., Mady E., Stasiecki P., Fohanno D., Gropp P., Poisson M., Delattre J-Y. A Phase I Study of an Anti-epidermal Growth Factor Receptor Monoclonal Antibody for the Treatment of Malignant Gliomas. Neurosurgery 1996; 39: 478–483
   PubMed Web of Science ®Google Scholar
• Fine HA. Novel biological therapies for malignant gliomas. Anti angiogenesis, immunotherapy, and gene therapy. Neurologic Clinics 1995; 13: 827–846
   Google Scholar
• Fountzilas G., Karavelis A., Makrantonakis P., et al. Concurrent radiation and intra carotid cisplatin infusion in malignant gliomas: a feasibility study. American J of Clinical Oncology 1997; 20: 138–142
   Google Scholar
• Fowler JF. What is next in fractionated radiotherapy?. British J Cancer 1984; 49((suppl. 6))S285–S300
   Google Scholar
• Fried M. P., Hsu L., Topulos G. P., Jolesz FA. Image-guided surgery in a new magnetic resonance suits: preclinical considerations. Laryngoscope 1996; 106: 411–417
   PubMed Web of Science ®Google Scholar
• Fueyo J., Gomez-Manzano C., Yung W. K., et al. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene 1996; 12: 103–110
   PubMed Web of Science ®Google Scholar
• Fujiwara T., Matsumoto Y., Honma Y., et al. A comparison of intra arterial carboplatin and ACNU for the treatment of gliomas. Surgical Neurology 1995; 44: 145–150
   Google Scholar
• Garrison J. I., Berens M. E., Shapiro J. R., et al. Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines. J of Neuro-Oncology 1996; 30: 213–223
   PubMedGoogle Scholar
• Ge K., Xu L., Zheng Z., Xu D., Sun L., Liu X. Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-Fluorocytosine. Int J of Cancer 1997; 71: 675–679
   Google Scholar
• Gomez-Manzano C., Fueyo J., Kyritsis A. P., et al. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Research 1996; 56: 694–699
   PubMed Web of Science ®Google Scholar
• Good D. J., Polverini P. J., Rastinejad F., Le Beau M. M., Lemons R. S., Frazier W. A., Bouck NP. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad of Sci USA 1990; 87: 6624–6628
   PubMed Web of Science ®Google Scholar
• Gould S., Darzi A. The magnetic resonance operating theater. British J of Surgery 1997; 84: 595–597
   Google Scholar
• Gupta N., Vij R., Haas-Kogan D. A., et al. Cytogenetic damage and the radiation-induced Gl-phase checkpoint. Radiation Research 1996; 145: 289–298
   PubMedGoogle Scholar
• Haapasalo H., Isola J., Sallinen F., et al. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. Amer J of Pathology 1993; 142: 1347–1351
   PubMed Web of Science ®Google Scholar
• Hall W. A., Djalilian H. R., Sperduto P. W., et al. Stereotactic radiosurgery for recurrent malignant gliomas. J of Clinical Oncology 1995; 13: 1642–1648
   PubMed Web of Science ®Google Scholar
• Hama S., Sadatomo T., Yoshioka H., et al. Transformation of human glioma cell lines with the p16 gene inhibits cell proliferation. Anticancer Research 1997; 17: 1933–1938
   Google Scholar
• Hamel W., Westphal M., Shephard HM. Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease. J Neuro-Oncology 1993; 16: 159–165
   Google Scholar
• Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353–364
   PubMed Web of Science ®Google Scholar
• Harada K., Yoshida J., Mizuno M., et al. Growth inhibition of intracerebral rat glioma by transfection-induced human interferon-beta. J of Surgical Oncology 1995; 59: 105–109
   PubMed Web of Science ®Google Scholar
• Hayes R. L., Koslow M., Hieseiger EM, et al. Improved long term survival after intracavitary inter-leukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma. Cancer 1995; 76: 840–852
   PubMed Web of Science ®Google Scholar
• Hochberg F., Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980; 30: 907–911
   PubMed Web of Science ®Google Scholar
• Hopkins K., Chandler C., Bullimore J., et al. A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral yttrium-90 radioimmunoconjugates. Radiotherapy Oncology 1995; 34: 121–131
   PubMedGoogle Scholar
• Isacson O., Breakefield XO. Benefits and risks of hosting animal cells in the human brain. Nature Medicine 1997; 3: 964–969
   PubMed Web of Science ®Google Scholar
• Izquierdo M., Martin V., De Felipe P., Izquierdo J. M., et al. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/gangoclovir gene therapy. Gene Therapy 1996; 3: 491–495
   PubMed Web of Science ®Google Scholar
• Kelland L. R., Edwards S. M., Steel GG. Induction and rejoining of DNA double-strand breaks in human cervix carcinoma cell lines of differing radiosensitiv-ity. Radiation Res 1988; 116: 526–538
   PubMed Web of Science ®Google Scholar
• Kim S. H., Kim J. H., Kolozsvary A., et al. Preferential radiosensitization of 9L glioma cells transduced with HSV-tk gene by acyclovir. J of Neuro-Oncology 1997; 33: 189–194
   PubMed Web of Science ®Google Scholar
• Kiu M. C., Chang C. N., Cheng W. C., et al. Combination chemotherapy with carmustine and cisplatin before, during and after radiotherapy for adult malignant gliomas. J of Neuro-Oncology 1995; 25: 215–220
   Google Scholar
• Kramm C. M., Rainov N. G., Sena-Esteves M., et al. Long-term survival in a rodent model of disseminated brain tumors by combined intra-thecal delivery of herpes vectors and glancoclovir treatment. Human Gene Therapy 1996; 7: 1989–1994
   PubMed Web of Science ®Google Scholar
• Kroll R. A., Pagel M. A., Muldoon L. L., Roman-Goldstein S., Neuwelt EA. Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor. Neurosurgery 1996; 38: 746–752
   PubMed Web of Science ®Google Scholar
• Kruse C. A., Roper M. D., Kleinschmidt-De Masters B. K., et al. Purified herpes simplex thymidine kinase Retrovector particles. Cancer Gene Therapy 1997; 4: 118–128
   Google Scholar
• Kuchelmeister K., Elborg B., Gullotta F. Immuno-histochemical detection of p53 protein in tumors of the central nervous system. Pathologica 1995; 87: 498–502
   Google Scholar
• Kyritsis A. P., Yung W. K., Jaeckle K. A., et al. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas. Neurosurgery 1996; 39: 921–926
   PubMed Web of Science ®Google Scholar
• Lai Y. S., Ramsay D. A., Macdonald D. R., Del Maestro RF. Therapy-related chromosomal changes and cytogenetic heterogeneity in human gliomas. J of Neuro-Oncology 1997; 32: 7–17
   Google Scholar
• Lamond J. P., Mehta M. P., Boothman DA. The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation. J Neuro-Oncology 1996; 30: 1–6
   PubMed Web of Science ®Google Scholar
• Levine A. L., Sheline G. E., Putin PH. Cancer: principles and practice of oncology. Davita, , et al, Lippincott, Philadelphia 1989; 1557–1611
   Google Scholar
• Levy R. M., Ward S., Schalgeter K., Groothuis D. Alternative delivery systems for antiviral nucleosides and antisense oligonucleotides to the brain. J of Neuro-Virology 1997; 3((suppl.l))S74–S75
   Google Scholar
• Libermann T. A., Nusbaum H. R., Razon N, et al. Amplification, enhanced expression and possible rearrangement of the EGF receptor gene in primary human brain tumors of glial origin. Nature 1985; 313: 144–147
   PubMed Web of Science ®Google Scholar
• Liu L., Barth R. F., Adams D. M., Soloway AH. Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. J Hema-totherapy 1995; 4: 477–483
   PubMedGoogle Scholar
• Lichtor T., Glick R. P., Kim T. S., et al. Prolonged survival of mice with glioma injected intra cerebrally with double cytokine-secreting cells. J of Neurosurgery 1995; 83((6))1038–1044
   Google Scholar
• Liotta L. A., Steeg P. S., Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327–336
   PubMed Web of Science ®Google Scholar
• Lorusso L., Nano R., Capelli E., et al. Activated lymphocytes in glioblastoma: significance for antitumoral immunity. Acta Neurologica 1994; 16: 198–205
   Google Scholar
• Lund R. D., Zhou H-F, Yee KT. The migration of astrocytes after implantation to immature brains. J Dev Neuroscience 1993; 11: 595–601
   Google Scholar
• Maron A., Gustin T., Le Roux A., et al. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging. Gene Therapy 1996; 3: 315–322
   PubMed Web of Science ®Google Scholar
• Matsumoto Y., Fujiwara T., Nagao S. Determinants of drug response in camptothecin-11 -resistant glioma cell lines. J Neuro-Oncology 1995; 23: 1–8
   PubMed Web of Science ®Google Scholar
• Mayol X., Garriga J., Grana X. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 1995; 11: 801–806
   PubMed Web of Science ®Google Scholar
• Mineta T., Rabkin S. D., Yazaki T., Hunter W. D., Martuza RL. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nature Medicine 1995; 1: 938–943
   PubMed Web of Science ®Google Scholar
• Miyamoto C., Brady L. W., Rackover M., et al. Utilization of 125I monoclonal antibody in the management of primary glioblastoma multiforme. Radiation Oncology Investigations 1995; 3: 126–132
   Google Scholar
• Mizuno M., Yoshida J. Tumor necrosis factor-alpha gene transfer agents anti-Fas antibody mediated apoptosis in human glioma cells. Jap Journal of Cancer Research 1996; 87: 543–547
   Google Scholar
• Muldoon L. L., Nilaver G., Kroll R. A., Pagel M. A., Breakefield X. O., Chiocca E. A., Davidson B. L., Weissleder R., Neuwelt EA. Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brains. American J of Pathology 1995; 147: 1840–1851
   PubMed Web of Science ®Google Scholar
• Nakagawa H., Fujita T., Kubo S., et al. Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: a preliminary report. Surgical Neurology 1994; 41: 19–27
   Google Scholar
• Nakagawa Y., Hatanaka H. Boron neutron capture therapy. Clinical brain tumor studies. J Neuro-Oncology 1997; 33: 105–115
   PubMed Web of Science ®Google Scholar
• Nakatsu S., Knodo S., Knodo Y., Yin D., Peterson J. W., Kaakaji R., Morimura T., Kikuchi J., Barnett GH. Induction of apoptosis in multi-drug resistant human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11. Cancer chemotherapy and Pharmacology 1997; 39: 417–423
   PubMed Web of Science ®Google Scholar
• Natali P. G., Nicotra Bigotti M. R., et al. Comparative analysis of the expression of the extracellular-matrix protein tenascin in normal and human fetal, adult and tumor tissues. Int J of Cancer 1991; 47: 811–816
   PubMed Web of Science ®Google Scholar
• Nehashi K., Yoshida J., Wakabayashi T., et al. Growth inhibition of human glioma cells by superinduced human interferon-beta. Neurologia Medico-Chirurgica 1995; 35: 719–722
   Google Scholar
• Nilaver G., Muldoon L. L., Kroll R. A., Pagel M. A., Breakefield X. O., Davidson B. L., Neuwelt EA. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proceedings of Nat Academy of Sciences of USA 1995; 92: 9829–9833
   PubMed Web of Science ®Google Scholar
• Nelson D. F., Curran W. J., Scott C., Nelson J. S., Weinstein A. S., Ahmad K., Constine L. S., Murray K., Powlis W. D., Mohiuddin M., Fischbach J. Hyperfractionated radiation therapy and bis-chloroethyl nitrosurea in the treatment of malignant glioma. Int J Radiation Oncology Biol Phys 1993; 25: 193–207
   PubMed Web of Science ®Google Scholar
• Neuwelt E. A., Weissleder R., Nilaver G. Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery 1994; 34: 777–784
   PubMed Web of Science ®Google Scholar
• Ohta S., Yanagihara K., Nagata K. Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta. Biochemical Journal 1997; 324: 777–782
   PubMed Web of Science ®Google Scholar
• Okada H., Miyamura K., Itoh T., et al. Gene therapy against an experimental glioma using adeno-associated virus vectors. Gene Therapy 1996; 3: 957–964
   PubMed Web of Science ®Google Scholar
• Okamoto S., Yoshikawa K., Obata Y., Shibuya M., Aoki S., Yoshida J., Takahashi T. Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor. British J of Cancer 1996; 73: 1366–1372
   PubMed Web of Science ®Google Scholar
• Oldfield E. H., Ram Z., Culver K. W., et al. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Human Gene Therapy 1993; 4: 39–69
   PubMed Web of Science ®Google Scholar
• Packer RJ. Alternative therapies for children with brain stem gliomas: immunotherapy and gene therapy. Pediatric Neurosurg 1996; 24: 217–222
   Google Scholar
• Paggi M. G., Martelli F., Fanciulli M., et al. Defective human retinoblastoma protein identified by lack of interaction with the E1A oncoprotein. Cancer Research 1994; 54: 1098–1104
   Google Scholar
• Parr M. J., Manome Y., Tanaka T., Wen P., Kufe D. W., Kaelin WG, Fine HA. Tumor selective transgene expression in vivo mediated by an E2F responsive adenoviral vector. Nature Medicine 1997; 3: 1145–1149
   PubMed Web of Science ®Google Scholar
• Patel K., Rossell R. J., Bourne S., Walsh F. S., Kemshead JT. Int J Cancer 1989; 44: 1062–1068
   Google Scholar
• Peters L. J., Withers H. R., Thames HD. Radiobiologi-cal bases for multiple daily fractionation. Progress in radio-oncology II, D. H. Kaercher, H. D Kogelnik, G. Reinartz. Raven Press, New York 1982; 317–323
   Google Scholar
• Prados M. D., Warnick R. E., Mack E. E., et al. Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial. American J of Clinical Oncology 1996; 19: 609–612
   PubMed Web of Science ®Google Scholar
• Press O. W., Vitetta E. S., Farr A. G., et al. Evaluation of ricin A-chain immunotoxins directed against human T cells. Cellular Immunology 1986; 102: 10–20
   PubMed Web of Science ®Google Scholar
• Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71–74
   PubMed Web of Science ®Google Scholar
• Rampling R., Steward W., Paul J., Macham M. A., Harvey E., Eckley D. rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU. British J of Cancer 1994; 69: 541–545
   Google Scholar
• Reifenberger G., Prior R., Deckert M., Wechsler W. epidermal growth factor receptor expression and growth fraction in human tumors of the nervous system. Virchows Arch (A) 1989; 414: 147–155
   Google Scholar
• Rubin P., Gash D. M., Hansen J. T., Nelson D. F., Williams JP. Disruption of blood-brain barrier as the primary effect of CNS irradiation. Radiotherapy and Oncology 1994; 31: 51–60
   PubMed Web of Science ®Google Scholar
• Saleh M., Stacker S. A., Wilks AF. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Research 1996; 56: 393–401
   PubMed Web of Science ®Google Scholar
• Sandberg-Nordqvist A. C., Stahlbom P. A., Reinecke M., et al. Characterization of insulin-like growth factor I in human primary brain tumors. Cancer Research 1993; 53: 2475–2478
   PubMed Web of Science ®Google Scholar
• Schupack K., Malkin M., Anderson L., et al. The relationship between the technical accuracy of stereo-tactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence. Int J of Radiation Oncology Biol Phys 1995; 32: 1167–1176
   Google Scholar
• Schwartz J. L., Rotmensch J., Giovanazzi S., et al. Faster repair of DNA double-strand breaks in radio resistant human tumor cells. Int J Radiation Oncology Biol Phys 1988; 15: 907–912
   PubMed Web of Science ®Google Scholar
• Shepherd S. F., Laing R. W., Gosgrove V. P., Warrington A. P., Hines F., Ashley S. E., Brada M. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Rad Oncology Biol Phys 1997; 37: 393–398
   Google Scholar
• Shoenberg BS. In Oncology of the nervous system, MD Walker, (Nijhoff, Boston) 1983; 1–30
   Google Scholar
• Short M. P., et al. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J of Neuroscience Res 1990; 27: 427–439
   PubMed Web of Science ®Google Scholar
• Shrieve D. C., Loeffler JS. Advances in radiation therapy for brain tumors. Neurol Clinics 1995; 13: 773–793
   Google Scholar
• Sipos E. P., Tyler B., Piantadosi S., et al. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Cancer Chemotherapy & Pharmacology 1997; 39: 383–389
   PubMed Web of Science ®Google Scholar
• Sneed P. K., Mcdermot M. W., Gutin PH. Interstitial brachytherapy procedure for brain tumors. Seminars in Surg Oncology 1997; 13: 157–166
   Google Scholar
• Sobol R. E., Fakhrai H., Shawler D., et al. Inter-leukin-2 gene therapy in a patient with glioblastoma. Gene Therapy 1995; 2: 164–167
   PubMed Web of Science ®Google Scholar
• Tachibana I., Moto M., Adjei P. N., Gores G. J., Subramaniam M., Spelsberg T. C., Urrutia R. Over expression of the TGF-beta regulated Zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J of Clin Investigations 1997; 99: 2365–2374
   PubMedGoogle Scholar
• Takamiya Y., et al. An experimental model of retrovirus gene therapy for malignant tumors. J of Neuwsurgery 1993; 79: 104–110
   PubMed Web of Science ®Google Scholar
• Thames H. D., Peters L. J., Withers H. R., Fletcher GH. Accelerated fractionation vs. hyperfractionation: rationales for several treatments per day. Int J Radiation Oncology Biol Phys. 1983; 9: 127–138
   PubMed Web of Science ®Google Scholar
• Trojan J., Johnson T. R., Rudin S. D., et al. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 1993; 259: 94–97
   PubMedGoogle Scholar
• Tsugu A., Kijima H., Yamazaki H., Ohnishi Y., Takamiya Y., Abe Y., Ueyama Y., Sato O., Tamaoki N., Nakamura M. Localization of aberrant messenger RNA of epidermal growth factor receptor (EGFR) in malignant glioma. Anticancer Research 1997; 17: 2225–2232
   PubMed Web of Science ®Google Scholar
• Tuzi N. L., Venter K. J., Kumar S., Staddon S. L., Lemoine L. R., Gullick WJ. Expression of growth factor receptors in human brain tumors. Br J Cancer 1991; 63: 227–233
   PubMed Web of Science ®Google Scholar
• Uhm J. H., Dooley N. P., Villemure J. G., Yong VO. Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can J Neurological Sci 1997; 24: 3–15
   PubMed Web of Science ®Google Scholar
• Uhrbom L., Nister M., Westermark B. Induction of senescence in human malignant glioma cells by p16INK4A. Oncogene 1997; 15: 505–514
   PubMedGoogle Scholar
• Valtonen S., Timonen U., Toivanen P., et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neuwsurgery 1997; 41: 44–48
   PubMed Web of Science ®Google Scholar
• Van Tassel P., Bruner J. M., Maor M. H., et al. MRI of toxic effects of accelerated fractionation radiation therapy and carboplatin chemotherapy for malignant gliomas. American J of Neuroradiology 1995; 16: 715–726
   Google Scholar
• Waldman T., Zhang Y., Dillehay L., et al. Cell-cycle arrest versus cell death in cancer therapy. Nature. Medicine 1997; 3: 1034–1036
   Google Scholar
• Wara W. M., Edwards MSB, Levin VA, et al. A new treatment regimen for brainstem glioma: a pilot study of the Brain Tumor Research Center and Children's Cancer Study Group. Int J of Radiation Oncology Biol Phys 1986; 12((suppl.l))143–144
   Google Scholar
• Warnick R. E., Prados M. D., Mack E. E., et al. A phase II study of intravenous carboplatin for the treatment of recurrent gliomas. J of Neuro-Oncology 1994; 19: 69–74
   PubMed Web of Science ®Google Scholar
• Weidner N. Angiogenesis in breast cancer. Cancer Treatment Res. 1996; 83: 265–301
   PubMedGoogle Scholar
• Wiener HL. The role of growth factor receptors in central nervous system development and neoplasia. Neuwsurgery 1995; 37: 179–193
   Google Scholar
• Weingart J. D., Thompson R. C., Tyler B., Colvin O. M., Brem H. Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model. Int J of Cancer 1995; 62: 605–609
   PubMed Web of Science ®Google Scholar
• Werner-Wasik M., Scott C. B., Nelson D. F., Gaspai L. E., Murray K. J., Fischback J. A., Nelson J. S., Weinstein A. S., Curran WJ. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustin for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83–02. Cancer 1996; 77: 1535–1543
   Google Scholar
• Wikstrand C. J., Mclendon R. E., Friedman A. H., Bigner DD. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Research 1997; 57: 4130–4140
   PubMed Web of Science ®Google Scholar
• Wlodek D., Hittelman WN. The repair of double-strand DNA breaks correlates with radiosensitivity of L5178Y-S and L5178Y-R cells. Radiation Res 1987; 112: 146–155
   PubMed Web of Science ®Google Scholar
• Yahanada A. M., Bruner J. M., Donehower L. A., Morrison RS. Astrocytes derived from p53-deficient mice provide a multi-step in vitro model for development of malignant gliomas. Molecular & Cellular Biology 1995; 15: 4249–4259
   Google Scholar
• Yokoyama S., Ohishi N., Shamoto M., et al. Isolation and expression of rat interferon beta gene and growth-inhibitory effect of its expression on rat glioma cells. Biochemical & Biophysical Research Communications 1997; 232: 698–701
   PubMed Web of Science ®Google Scholar
• Yang W., Barth R. F., Rotaru J. H., Moeschberger M. L., Joel D. D., Nawrocky M. M., Goodman J. H., Soloway AH. Boron-Neutron capture therapy of brain tumors: enhanced survival following intracrotid injection of sodium borocaptate with or without blood brain barrier disruption. Int J Radion Oncology Biolog Physics 1997; 37: 663–672
   Google Scholar
• Yu J. S., Burwick J. A., Dranoff G., Breakefield XO. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells. Human Gene Therapy 1997; 8: 1065–1072
   PubMed Web of Science ®Google Scholar
• Zhu J., Zhang L., Hanisch U. K., Feigner P. L., Reszka R. Continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy. Gene Therapy 1996; 3: 476–476
   Google Scholar